UROwebinar: The role of MRI in prostate cancer screening and diagnosis
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | 1.00 |
| Location | Online |
This is the second episode of the new UROwebinar series “Prostate Cancer Screening: PRAISE U training toolbox” organised by the European School of Urology, the EAU Policy Office, and the PRAISE-U Consortium. This UROwebinar will begin with a brief recap of the previous episode.
The UROwebinar will explore the role of MRI in prostate cancer (PCa) screening and diagnosis, focusing on recent clinical trials such as Gothenburg and TRANSFORM. The experts will discuss how MRI-guided screening is transforming early detection, biopsy rates, and diagnostic accuracy.
This UROwebinar will also highlight debates on the applicability of trial findings to broader populations, as well as the potential impact on real-world screening protocols and patient outcomes.
Additionally, the UROwebinar will examine the implications for radiologists and urologists, which will include the feasibility of MRI-first screening and its integration into clinical practice across Europe.
A dedicated lecture will focus on artificial intelligence (AI) advancements in MRI interpretation, exploring how emerging technologies may enhance PCa detection and streamline workflows.
Faculty
Dr R. Van Den Bergh (NL)
Prof. H. Van Poppel (BE)
Dr V. Kasivisvanathan (GB)
Dr. J. Wallstrom (SE)
Dr. I.G. Schoots (NL)
Dr. A. Chandran (FR)
